Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol (2010) 4.06

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94

Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol (2010) 2.50

Uric acid transport and disease. J Clin Invest (2010) 2.33

Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect (2010) 2.16

Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2011) 2.14

Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum (2009) 2.07

Increased fructose associates with elevated blood pressure. J Am Soc Nephrol (2010) 2.01

Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem (2012) 1.67

Genotype-based changes in serum uric acid affect blood pressure. Kidney Int (2011) 1.62

Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study. Am J Hypertens (2014) 1.48

The genetics of hyperuricaemia and gout. Nat Rev Rheumatol (2012) 1.47

Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) (2013) 1.47

Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. J Am Coll Cardiol (2016) 1.46

Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol (2009) 1.44

Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure. Int J Cardiol (2013) 1.44

Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study. Am J Med (2015) 1.42

Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes. J Clin Hypertens (Greenwich) (2014) 1.41

A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol (2011) 1.40

Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort. PLoS One (2017) 1.39

Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism (2011) 1.27

Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci U S A (2010) 1.23

Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens (2009) 1.22

Uric acid as a target of therapy in CKD. Am J Kidney Dis (2012) 1.22

Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension (2012) 1.21

Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep (2013) 1.20

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol (2014) 1.19

Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect (2010) 1.16

Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol (2011) 1.16

Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism (2011) 1.15

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol (2013) 1.15

Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09

Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol (2014) 1.08

Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. J Am Soc Nephrol (2015) 1.08

Uric acid as one of the important factors in multifactorial disorders--facts and controversies. Biochem Med (Zagreb) (2012) 1.05

Essential hypertension and oxidative stress: New insights. World J Cardiol (2014) 1.04

Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One (2014) 1.04

Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study. Arthritis Care Res (Hoboken) (2013) 1.03

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial. Clin Exp Nephrol (2015) 1.03

Risk factors for progression of chronic kidney disease. Curr Opin Pediatr (2010) 1.03

Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? Semin Nephrol (2012) 1.02

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation. Nat Commun (2015) 1.01

Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene. Trans Am Clin Climatol Assoc (2010) 1.01

Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. Arthritis Rheum (2012) 1.00

Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich) (2012) 0.98

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther (2009) 0.98

A review of uric acid, crystal deposition disease, and gout. Adv Ther (2014) 0.97

Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab (2013) 0.97

Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord (2013) 0.97

Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med (2013) 0.95

Recent clinical and translational advances in pediatric hypertension. Hypertension (2015) 0.95

The immunological basis of hypertension. Am J Hypertens (2014) 0.94

Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010. J Am Heart Assoc (2014) 0.94

Hyperuricemia and incident heart failure. Circ Heart Fail (2009) 0.92

The metabolic and endocrine response and health implications of consuming sugar-sweetened beverages: findings from recent randomized controlled trials. Adv Nutr (2013) 0.92

Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice. Br J Pharmacol (2015) 0.91

Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD. J Am Soc Nephrol (2012) 0.91

[Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)]. Z Rheumatol (2016) 0.91

Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 0.90

Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nat Rev Nephrol (2011) 0.90

Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. J Biol Chem (2010) 0.90

Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis (2012) 0.90

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant (2012) 0.89

Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. PLoS One (2013) 0.89

Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord (2012) 0.89

Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Am J Nephrol (2009) 0.89

Risk of incident diabetes in patients with gout: a cohort study. Arthritis Rheumatol (2015) 0.89

Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension. Kidney Blood Press Res (2012) 0.88

Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients. Pediatr Nephrol (2011) 0.88

Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol (2011) 0.88

Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med (2015) 0.87

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review. Nephrourol Mon (2015) 0.87

IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol (2014) 0.86

Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. Am J Kidney Dis (2015) 0.86

Uric acid levels predict future blood pressure and new onset hypertension in the general Japanese population. J Hum Hypertens (2014) 0.86

The effect of normally consumed amounts of sucrose or high fructose corn syrup on lipid profiles, body composition and related parameters in overweight/obese subjects. Nutrients (2014) 0.86

Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients. BMC Nephrol (2014) 0.86

Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. Metabolism (2011) 0.86

The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease. Cardiovasc Psychiatry Neurol (2009) 0.86

Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients. Heart Vessels (2016) 0.85

World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1. Diabetes Care (2011) 0.85

Efficacy and safety of febuxostat in patients with hyperuricemia and gout. Ther Adv Musculoskelet Dis (2011) 0.85

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia. J Res Med Sci (2012) 0.85

Uric acid, CKD, and cardiovascular disease: confounders, culprits, and circles. Am J Kidney Dis (2010) 0.85

[Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia]. Z Rheumatol (2012) 0.85

Hyperuricemia, Cardiovascular Disease, and Hypertension. Pulse (Basel) (2016) 0.84

The effects of fructose-containing sugars on weight, body composition and cardiometabolic risk factors when consumed at up to the 90th percentile population consumption level for fructose. Nutrients (2014) 0.84

Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses (2010) 0.84

Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia. Hypertens Res (2016) 0.83

Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Res Ther (2012) 0.83

Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study. PLoS One (2015) 0.83

Vascular Function and Uric Acid-Lowering in Stage 3 CKD. J Am Soc Nephrol (2016) 0.83

Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease. Nephrol Dial Transplant (2015) 0.83

Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population: a hospital based cross sectional study. Asian Pac J Trop Biomed (2014) 0.82

Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth. Pediatr Nephrol (2015) 0.82

Plasma bicarbonate and odds of incident hypertension. Am J Hypertens (2013) 0.82

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA (1993) 6.27

Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet (2001) 6.05

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41

Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics (2004) 4.18

Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation (2002) 3.72

Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension (2004) 3.51

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation (2006) 3.48

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension (2003) 3.39

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37

Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr (1997) 3.29

Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol (2007) 2.71

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation (2002) 2.71

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47

Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension (2004) 2.46

Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). J Pediatr (Rio J) (2006) 2.46

Uric acid and the development of hypertension: the normative aging study. Hypertension (2006) 2.45

Hyperuricemia in childhood primary hypertension. Hypertension (2003) 2.39

Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension (2006) 2.31

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol (1990) 2.27

Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol (2005) 2.24

Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22

Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension (2006) 2.18

Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension (2006) 1.90

Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol (2004) 1.83

Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol (2006) 1.74

Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73

State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens (Greenwich) (2008) 1.38

Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol (2006) 1.33

Effect of a research nurse on patient enrollment in a clinical study. Pediatr Emerg Care (1996) 1.30

Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract (2005) 1.24

Uric acid and diet--insights into the epidemic of cardiovascular disease. N Engl J Med (2004) 1.15

Serum uric acid and the renin-angiotensin system in hypertension. J Am Geriatr Soc (1978) 1.12

The adolescent with essential hypertension. Am J Kidney Dis (1985) 1.00

On Uric Acid and Arterial Tension. Br Med J (1889) 1.00

Reproducibility of impedance cardiography hemodynamic measures in clinically stable heart failure patients. Congest Heart Fail (2002) 0.94

Risk factors for cardiovascular disease: one down, many more to evaluate. Ann Intern Med (1999) 0.94

Simultaneous administration of multiple model substrates to assess hepatic drug clearance. Clin Pharmacol Ther (1987) 0.93

Impedance cardiography (ICG) noninvasive hemodynamic monitoring provides an opportunity to deliver cost effective, quality care for patients with cardiovascular disorders. J Cardiovasc Manag (2000) 0.93

Measurement of exercise cardiac output by thoracic impedance in healthy children. Eur J Appl Physiol (2004) 0.89

A continuous fluorescence assay of renin activity. Anal Biochem (1993) 0.89

Effects of antihypertensive drugs on blood pressure and proteinuria in childhood. J Hypertens (2007) 0.89

The view within: the emerging technology of thoracic electrical bioimpedance. Crit Care Nurs Q (1998) 0.85

Impedance cardiography: a bridge between research and clinical practice in the treatment of heart failure. Congest Heart Fail (2002) 0.85

Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20

Hyperuricemia induces endothelial dysfunction. Kidney Int (2005) 5.36

A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2005) 4.95

A role for uric acid in the progression of renal disease. J Am Soc Nephrol (2002) 3.77

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology (2010) 3.73

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol (2005) 3.73

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension (2003) 3.39

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37

Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol (2008) 3.33

Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol (2007) 3.08

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78

Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol (2007) 2.71

Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol (2009) 2.70

Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol (2002) 2.51

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int (2010) 2.47

Hyperuricemia in childhood primary hypertension. Hypertension (2003) 2.39

Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J Clin Hypertens (Greenwich) (2012) 2.37

Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun (2013) 2.29

Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol (2008) 2.28

Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol (2005) 2.24

Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol (2007) 2.24

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol (2003) 2.24

Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension (2006) 2.02

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int (2005) 2.02

Increased fructose associates with elevated blood pressure. J Am Soc Nephrol (2010) 2.01

TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int (2004) 1.95

Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol (2006) 1.94

Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J (2003) 1.93

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol (2002) 1.89

J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis (2006) 1.88

Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol (2002) 1.86

Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol (2003) 1.84

Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol (2006) 1.83

CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol (2013) 1.83

Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes (2011) 1.82

Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med (2006) 1.81

Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens (2010) 1.80

Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids (2008) 1.76

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes (2009) 1.76

Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol (2004) 1.76

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2007) 1.74

Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A (2012) 1.72

Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol (2008) 1.72

Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis (2007) 1.71

Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens (2004) 1.71

Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol (2008) 1.69

Molecular physiology of urate transport. Physiology (Bethesda) (2005) 1.69

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol (2009) 1.69

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol (2008) 1.68

Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol (2003) 1.68

Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem (2012) 1.67

Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant (2010) 1.65

The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med (2008) 1.65

Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol (2007) 1.65

Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol (2002) 1.64

Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63

Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids (2008) 1.59

The role of uric acid in the pathogenesis of human cardiovascular disease. Heart (2013) 1.59

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care (2013) 1.58

Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl (2003) 1.57

Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology (2012) 1.57

Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol (2006) 1.56

High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology (2013) 1.56

Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant (2008) 1.55

Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation. Kidney Int (2011) 1.55

Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol (2006) 1.54

Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Acta Diabetol (2014) 1.48

Effects of cyclosporine in osteopontin null mice. Kidney Int (2002) 1.47

Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol (2008) 1.46

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant (2010) 1.45

Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol (2010) 1.43

Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int (2004) 1.42

IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol (2005) 1.41

Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes. J Clin Hypertens (Greenwich) (2014) 1.41

A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol (2011) 1.40

Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol (2002) 1.39

Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2008) 1.38

Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension (2004) 1.38

Serum uric acid: a risk factor and a target for treatment? J Am Soc Nephrol (2006) 1.35

Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol (2010) 1.34

Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol (2005) 1.33

Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol (2006) 1.33

Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J Physiol Renal Physiol (2008) 1.28

Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism (2011) 1.27

Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One (2012) 1.24

Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index? Eur J Nutr (2007) 1.24

Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway. Nephrol Dial Transplant (2011) 1.23

Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl (2005) 1.23

A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant (2009) 1.21

Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol (2002) 1.19

Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol (2013) 1.18

Diabetic eNOS-knockout mice develop accelerated retinopathy. Invest Ophthalmol Vis Sci (2010) 1.18

Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis. Am J Physiol Renal Physiol (2003) 1.18

Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci U S A (2014) 1.18

Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension. Am J Physiol Renal Physiol (2006) 1.16

Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism (2011) 1.15